A detailed history of Bank Of America Corp transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Bank Of America Corp holds 5,218 shares of CGTX stock, worth $2,295. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,218
Previous 5,000 4.36%
Holding current value
$2,295
Previous $9,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.66 - $2.62 $361 - $571
218 Added 4.36%
5,218 $8,000
Q1 2024

May 15, 2024

SELL
$1.78 - $2.53 $24 - $35
-14 Reduced 0.28%
5,000 $9,000
Q4 2023

Feb 14, 2024

BUY
$0.96 - $2.42 $4,813 - $12,133
5,014 New
5,014 $9,000
Q4 2022

Feb 10, 2023

BUY
$1.17 - $3.51 $53 - $161
46 New
46 $0

Others Institutions Holding CGTX

About COGNITION THERAPEUTICS INC


  • Ticker CGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,710,700
  • Market Cap $9.99M
  • Description
  • Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...
More about CGTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.